ATNM Earnings

Quarterly EPS
$-0.38
Q2 2024
$-0.37
Q3 2024
$-0.21
Q4 2024
$-0.51
Q1 2025
$-0.22
Q2 2025
$-0.16
Q3 2025
$-0.19
Q4 2025
$-0.18
Q1 2026
Latest RevenueN/A
Latest Net Income-5522000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.180-5522000+64.7%
Q4 2025-$0.190-5940000+9.5%
Q3 2025-$0.1690.0K-5131000+56.8%
Q2 2025-$0.220-6878000+42.1%
Q1 2025-$0.510-15938000-64.5%
Q4 2024-$0.210-6652000-100.0%+38.2%
Q3 2024-$0.370-11568000+24.5%
Q2 2024-$0.380-11353000+34.5%
Q1 2024-$0.310-8670000
Q4 2023-$0.3481.0K-9324000
Q3 2023-$0.490-13276000
Q2 2023-$0.580-15181000
Actinium Pharmaceuticals (ATNM) — Earnings